PRECISION BIOSCIENCES INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| List Alan | Chief Medical Officer | Option Exercise | 982 | — | — | 4,778 | May 2, 2024 |
| Amoroso Michael | President and CEO | Option Exercise | 3,417 | — | — | 15,298 | May 2, 2024 |
| List Alan | Chief Medical Officer | Option Exercise | 868 | — | — | 4,034 | Apr 30, 2024 |
| Kelly John Alexander | Chief Financial Officer | Option Exercise | 1,702 | — | — | 22,680 | Feb 29, 2024 |
| SMITH J. JEFFERSON | Chief Research Officer | Option Exercise | 75,015 | — | — | 2,015,269 | Jan 23, 2024 |
| Amoroso Michael | President and CEO | Option Exercise | 266,720 | — | — | 493,823 | Jan 22, 2024 |
| List Alan | Chief Medical Officer | Option Exercise | 60,012 | — | — | 116,508 | Jan 22, 2024 |
| Kelly John Alexander | Chief Financial Officer | Option Exercise | 116,690 | — | — | 614,169 | Jan 20, 2024 |
| Scimeca Dario | General Counsel and Secretary | Sale | 21,287 | $0.36 | $7,663 | 151,028 | Jan 20, 2024 |
| Scimeca Dario | General Counsel and Secretary | Option Exercise | 55,077 | — | — | 128,993 | Nov 3, 2023 |
| Amoroso Michael | President and CEO | Sale | 125,025 | $0.40 | $50,010 | 227,103 | Nov 2, 2023 |
| Kelly John Alexander | Chief Financial Officer | Option Exercise | 108,188 | — | — | 497,479 | Nov 2, 2023 |
| Scimeca Dario | General Counsel and Secretary | Award / Grant | 5,443 | $0.39 | $2,123 | 73,916 | Aug 31, 2023 |
| SMITH J. JEFFERSON | Chief Research Officer | Award / Grant | 5,175 | $0.39 | $2,018 | 1,940,254 | Aug 31, 2023 |
| Kelly John Alexander | Chief Financial Officer | Award / Grant | 5,951 | $0.39 | $2,321 | 389,291 | Aug 31, 2023 |
| Kelly John Alexander | Chief Financial Officer | Award / Grant | 90,000 | $0.48 | $43,200 | 383,340 | Aug 18, 2023 |
| Kelly John Alexander | Chief Financial Officer | Purchase | 90,000 | $0.48 | $43,200 | 383,340 | Aug 18, 2023 |
| Barton Shane | VP & Corporate Controller | Option Exercise | 6,060 | — | — | 27,502 | Jun 7, 2023 |
| Kelly John Alexander | Chief Financial Officer | Option Exercise | 34,091 | — | — | 279,705 | Jun 7, 2023 |
| SMITH J. JEFFERSON | Chief Research Officer | Option Exercise | 4,872 | — | — | 1,935,079 | Jun 7, 2023 |
| Scimeca Dario | General Counsel and Secretary | Sale | 13,361 | $0.75 | $10,021 | 68,473 | Jun 7, 2023 |
| List Alan | Chief Medical Officer | Option Exercise | 26,027 | — | — | 64,267 | Apr 27, 2023 |
| Buehler Kevin | — | Option Exercise | 5,701 | — | — | 5,701 | Apr 11, 2023 |
| Amoroso Michael | President and CEO | Option Exercise | 102,535 | — | — | 115,737 | Mar 22, 2023 |
| Kelly John Alexander | Chief Financial Officer | Purchase | 20,000 | $0.86 | $17,200 | 245,614 | Mar 17, 2023 |
| Scimeca Dario | General Counsel and Secretary | Sale | 12,172 | $1.07 | $13,024 | 50,063 | Mar 3, 2023 |
| List Alan | Chief Medical Officer | Sale | 9,473 | $1.07 | $10,136 | 38,240 | Mar 3, 2023 |
| SMITH J. JEFFERSON | Chief Research Officer | Award / Grant | 12,157 | $0.95 | $11,549 | 1,914,631 | Mar 3, 2023 |
| Kelly John Alexander | Chief Financial Officer | Award / Grant | 11,605 | $0.95 | $11,025 | 174,543 | Mar 3, 2023 |
| Barton Shane | VP & Corporate Controller | Option Exercise | 12,722 | — | — | 21,422 | Mar 3, 2023 |
| Amoroso Michael | President and CEO | Sale | 11,006 | $1.32 | $14,528 | 13,202 | Oct 15, 2022 |
| Kelly John Alexander | Chief Financial Officer | Purchase | 37,037 | $1.34 | $49,630 | 154,738 | Sep 23, 2022 |
| Kelly John Alexander | Chief Financial Officer | Purchase | 33,784 | $1.50 | $50,676 | 117,701 | Jun 22, 2022 |
| JANTZ DEREK | Chief Scientific Officer | Sale | 18,849 | $2.06 | $38,829 | 4,055,174 | Jun 7, 2022 |
| Scimeca Dario | General Counsel and Secretary | Option Exercise | 22,727 | — | — | 33,300 | Jun 7, 2022 |
| Kelly John Alexander | Chief Financial Officer | Option Exercise | 13,638 | — | — | 83,917 | Jun 7, 2022 |
| Barton Shane | VP & Corporate Controller | Option Exercise | 6,061 | — | — | 8,720 | Jun 7, 2022 |
| List Alan | Chief Medical Officer | Sale | 7,775 | $2.10 | $16,328 | 18,260 | Apr 26, 2022 |
| Kelly John Alexander | Chief Financial Officer | Purchase | 16,677 | $3.08 | $51,365 | 36,189 | Mar 17, 2022 |
| Barton Shane | VP & Corporate Controller | Award / Grant | 761 | $3.61 | $2,747 | 2,659 | Aug 31, 2021 |
| Kelly John Alexander | Chief Financial Officer | Award / Grant | 2,714 | $3.61 | $9,798 | 19,512 | Aug 31, 2021 |
| THOMSON DAVID S. | Chief Operating Officer | Sale | 30,000 | $10.65 | $319,500 | 111,513 | Jun 23, 2021 |
| THOMSON DAVID S. | Chief Operating Officer | Sale | 15,000 | $10.77 | $161,550 | 111,513 | Jun 21, 2021 |
| THOMSON DAVID S. | Chief Operating Officer | Option Exercise | 10,000 | $1.18 | $11,800 | 121,513 | Jun 17, 2021 |
| THOMSON DAVID S. | Chief Operating Officer | Sale | 2,858 | $11.20 | $32,010 | 111,513 | Jun 15, 2021 |
| THOMSON DAVID S. | Chief Operating Officer | Sale | 30,000 | $11.52 | $345,600 | 111,513 | Jun 11, 2021 |
| JANTZ DEREK | Chief Scientific Officer | Sale | 20,000 | $9.38 | $187,600 | 4,032,279 | May 17, 2021 |
| JANTZ DEREK | Chief Scientific Officer | Sale | 9,673 | $9.17 | $88,701 | 4,052,279 | May 14, 2021 |
| KANE MATTHEW R. | President and CEO | Sale | 9,675 | $8.96 | $86,688 | 2,013,597 | May 13, 2021 |
| JANTZ DEREK | Chief Scientific Officer | Option Exercise | 21,514 | $0.04 | $861 | 4,050,111 | May 13, 2021 |